Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Initial clinical experience with BAS O, a bioactive glass-ceramic material]

K Urban1, J Stehlík

  • 1Ortopedická klinika lékarské fakulty KU, Hradec Králové.

Acta Chirurgiae Orthopaedicae Et Traumatologiae Cechoslovaca
|January 1, 1993
PubMed
Summary

This study reports on early clinical use of a new bone-filling material called BAS O. Doctors used it in patients with various bone defects, including those from injuries and benign tumors. X-rays showed bone growing toward the material without forming a protective layer. No patients had healing problems or allergic reactions. Blood tests showed normal results except for temporary increases in a type of white blood cell. These findings suggest the material may be safe and effective for bone repair, but more research is needed to confirm these early results.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-otoplasty keloid scars - treatment strategies and case reports.

Acta chirurgiae plasticae·2026
Same author

Comparing DSA-negative and DSA-positive antibody-mediated rejection in heart transplants: Results from the Trifecta-Heart study.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

First Constraints on General Neutrino Interactions Based on KATRIN Data.

Physical review letters·2025
Same author

New Constraint on the Local Relic Neutrino Background Overdensity with the First KATRIN Data Runs.

Physical review letters·2022
Same author

Tunable Coupling Architecture for Fixed-Frequency Transmon Superconducting Qubits.

Physical review letters·2021
Same author

Sialadenitis as chickenpox complication in a 6-year-old girl.

IDCases·2021

Area of Science:

  • Orthopedic biomaterials research
  • Bioceramics in surgical applications
  • Regenerative medicine in trauma surgery

Background:

Orthopedic surgeons frequently encounter bone defects requiring filling with synthetic materials. While traditional options like autografts and allografts remain common, bioactive glass-ceramics have emerged as alternatives. Prior research has shown these materials can integrate with bone tissue over time. However, limited clinical data exists on their long-term performance in diverse patient populations. This gap motivated the need for a study focusing on real-world surgical outcomes. The authors aimed to address uncertainties around healing patterns and potential adverse effects. No prior work had resolved how these materials behave in traumatic versus pathological defects. This paper's contribution lies in its initial clinical observations from a small cohort.

Purpose Of The Study:

The research team aimed to evaluate the initial clinical performance of a specific bioactive glass-ceramic material called BAS O. They focused on how this material integrates with bone tissue in patients with various types of bone defects. The specific problem addressed was whether this material could safely promote healing without causing complications. Motivation came from the need for reliable synthetic bone graft substitutes. The study sought to determine if BAS O could avoid fibrous encapsulation and promote direct bone growth. Researchers also wanted to monitor any systemic effects from material use. The follow-up period was designed to capture early healing indicators. The goal was to establish a baseline for future larger trials.

Keywords:
bone graft materialbioactive ceramicsorthopedic surgerytissue integration

Frequently Asked Questions

X-ray imaging showed bone trabeculae approaching the material without fibrous encapsulation in all patients.

The material was used as granules for traumatic defects and as blocks for benign tumor-related defects.

Three-month intervals were based on prior experimental data suggesting this timeframe captures early integration patterns.

Eosinophilia was observed in eight patients postoperatively but resolved without intervention.

Related Experiment Videos

Main Methods:

The study involved 11 patients with surgically treated bone defects. Some defects were traumatic, while others included benign tumors and developmental conditions. The material was used in granular or block form depending on defect type. X-ray imaging was conducted at three-month intervals to track integration. Hematological and biochemical parameters were monitored regularly. No randomization or control groups were used in this initial clinical experience report. The authors relied on clinical observation and radiographic analysis. Patient selection criteria focused on defect type and surgical necessity. The study design emphasized qualitative assessment of healing patterns.

Main Results:

X-ray imaging showed progressive bone trabeculae approaching the material without fibrous encapsulation. No wound healing complications were reported in any patient. Laboratory tests remained within normal ranges for most parameters. Calcium levels stayed stable throughout the follow-up period. Phosphorus levels approached upper limits but did not exceed them. Alkaline phosphatase was elevated in several young patients. Eosinophilia was observed in eight patients postoperatively. These findings suggest the material did not trigger significant inflammatory responses.

Conclusions:

The authors report that BAS O material integrated with bone tissue without forming fibrous barriers. Clinical follow-up showed no surgical wound complications or allergic reactions. Radiographic evidence suggested direct bone growth toward the material. Hematological changes were limited to transient eosinophilia in most cases. These findings align with prior experimental data on bioactive glass-ceramics. The authors propose that this material may be suitable for filling bone defects. They suggest further investigation is needed to confirm these preliminary results. The three-month postoperative loading protocol appeared safe based on observed healing patterns.

Failed At:

2026-07-14T07:37:06.659986+00:00

Calcium levels remained within normal ranges throughout the 6 to 24 month observation period.

The authors propose this suggests the material promotes direct bone integration rather than forming a fibrous barrier.